Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cheyennedra C. Bieg‐Bourne"'
Publikováno v:
Molecular Oncology, Vol 14, Iss 6, Pp 1242-1251 (2020)
We examined the impact of spatial, temporal, histologic, and quantitative factors on concordance between TP53 alterations in tissue DNA vs in circulating tumor DNA (ctDNA). Four hundred and thirty‐three patients underwent next‐generation sequenci
Externí odkaz:
https://doaj.org/article/318382a4daed48129937195569c685ef
Autor:
Razelle Kurzrock, Barbara A. Parker, Juliann Chmielecki, Michael E. Goldberg, Paul T. Fanta, David E. Piccioni, Sherri Z. Millis, Cheyennedra C. Bieg-Bourne
Supplemental Table S2 displays the Foundation Medicine 315 gene panel for solid tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32b84ef1a4fed778121016a12cb2c3bb
https://doi.org/10.1158/0008-5472.22415378.v1
https://doi.org/10.1158/0008-5472.22415378.v1
Autor:
Razelle Kurzrock, Barbara A. Parker, Juliann Chmielecki, Michael E. Goldberg, Paul T. Fanta, David E. Piccioni, Sherri Z. Millis, Cheyennedra C. Bieg-Bourne
Enhancements in clinical-grade next-generation sequencing (NGS) have fueled the advancement of precision medicine in the clinical oncology field. Here, we survey the molecular profiles of 1,113 patients with diverse malignancies who successfully unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b012c116104b6bf9baaab4c1377aa81e
https://doi.org/10.1158/0008-5472.c.6509258.v1
https://doi.org/10.1158/0008-5472.c.6509258.v1
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 14, Iss 6, Pp 1242-1251 (2020)
Molecular Oncology, Vol 14, Iss 6, Pp 1242-1251 (2020)
We examined the impact of spatial, temporal, histologic, and quantitative factors on concordance between TP53 alterations in tissue DNA vs in circulating tumor DNA (ctDNA). Four hundred and thirty‐three patients underwent next‐generation sequenci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e56c9435a549e35c9f745b3e8141878e
https://doi.org/10.1002/1878-0261.12672
https://doi.org/10.1002/1878-0261.12672
Autor:
Barbara A. Parker, Juliann Chmielecki, Michael E. Goldberg, Razelle Kurzrock, Sherri Z. Millis, Cheyennedra C. Bieg-Bourne, Paul T. Fanta, David Piccioni
Publikováno v:
Cancer research, vol 77, iss 22
Enhancements in clinical-grade next-generation sequencing (NGS) have fueled the advancement of precision medicine in the clinical oncology field. Here, we survey the molecular profiles of 1,113 patients with diverse malignancies who successfully unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc5c96b4cd86fb516e12beb682387cb4
https://escholarship.org/uc/item/2pk0w6w4
https://escholarship.org/uc/item/2pk0w6w4